Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MAGELLAN HEALTH, INC.

(MGLN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Magellan Health : Rx Management's AIDS Drug Assistance Program Center of Excellence Expands Program That Significantly Improves Medication Adherence and Quality of Care for Patients with HIV

09/15/2021 | 06:31am EDT

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN) has expanded Navigate Whole Health to include the AIDS Drug Assistance Program (ADAP) that applies an innovative and comprehensive approach to managing the quality of care for persons receiving treatment for HIV. Through the program, clinical pharmacists partner with providers to manage complex cases by promoting best-practices for HIV treatment and closing care gaps. The Navigate Whole Health ADAP program also supports participating ADAPs in meeting Health Resources & Services Administration (HRSA) performance measures.

“Navigate Whole Health ADAP offers a unique opportunity to support participating ADAP customers, providers and their members by concentrating on HIV/AIDS treatments, comorbid chronic diseases, behavioral health conditions, and social determinants that interfere with outcomes,” said Caroline Carney, MD, chief medical officer, Magellan Health. “We are using data science to tailor interventions to deliver the right supports to prevent interruptions in therapy and address behavioral healthcare, including depression and substance abuse.”

Adherence to antiretroviral therapy (ART) is critical to reducing viral load, transmission, and resistance. For most patients, nearly perfect (>95 percent) adherence is necessary to achieve optimal viral suppression and clinical success. However, the national average rate of adherence to ART is around 70 percent, and the total annual unadjusted costs per patient for non-adherence to HIV ART therapy ranged from $16,957 to $30,068.1,2

The Navigate Whole Health ADAP pilot program was conducted for nine months. An analysis of the first three months of intervention shows a 26.7 percent increase in HIV/ART medication adherence in six months post intervention. This program also addresses behavioral concerns, like depression, and achieved a 60 percent increase in members being adherent to their antidepressant medication adherence. “It is particularly encouraging to note that 100% of the recommendations made by Magellan clinical team were accepted by prescribers,” says Astha Chopra, vice president, clinical effectiveness, Magellan Health.

ADAP Center of Excellence

Magellan Rx established a national ADAP Center of Excellence (COE) with a dedicated call center to provide timely service and continuity of care. The dedicated ADAP team provides a multi-faceted approach to State ADAP programs across the country with a best-in class operating paradigm to help improve patient outcomes and prevent HIV. Navigate ADAP is one of the ways the Magellan Rx ADAP COE helps improve clinical quality for ADAP members.

“With over three decades of experience in serving some of the largest state ADAP programs, our Magellan team is deeply invested in the national effort to combat AIDS and the HIV epidemic through education, awareness, research and access to medications for those living with the disease. We invested in the Center of Excellence to leverage significant expertise on behalf of all our ADAP customers and their members. This program is one of many examples of our commitment to this work.” Meredith Delk, general manager and senior vice president, government markets, Magellan Rx Management.

About Magellan Rx Management: Magellan Rx Management, a division of Magellan Health, Inc., is shaping the future of pharmacy. As a next-generation pharmacy organization, we deliver meaningful solutions to the people we serve. As pioneers in specialty drug management, industry leaders in Medicaid pharmacy programs and disruptors in pharmacy benefit management, we partner with our customers and members to deliver a best-in-class healthcare experience.

About Magellan Health: Magellan Health, Inc., is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

1.

Machtinger EL, Bangsberg DR. Adherence to HIV Antiretroviral Therapy. HIV in Site Knowledge Base Chapter; May. 2005. [Accessed on 2021 Mar 16]. Content Reviewed; January 2006. http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09.

2.

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. Published 2018 Jan 21. doi:10.1136/bmjopen-2017-016982

(MGLN-GEN)


© Business Wire 2021
All news about MAGELLAN HEALTH, INC.
10/13MAGELLAN HEALTH : Taps Healthcare Experts for Magellan Health Studio Advisory Council
BU
10/07MAGELLAN HEALTH : Rx Pharmacy Earns NABP Digital Pharmacy Accreditation
BU
10/04MAGELLAN HEALTHCARE : Debuts High-Touch, High-Tech Collaborative Care Management Solution ..
BU
10/04Magellan Healthcare Debuts High-Touch, High-Tech Collaborative Care Management Solution..
CI
09/30MAGELLAN HEALTH : Opens Free Crisis Hotline to Support First Responders, Healthcare Worker..
BU
09/30Magellan Health, Inc. Opens Free Crisis Hotline to Support First Responders, Healthcare..
CI
09/28MAGELLAN HEALTHCARE : Hosts Webinars in Support of National Depression and Mental Health A..
BU
09/15MAGELLAN HEALTH : Rx Management's AIDS Drug Assistance Program Center of Excellence Expand..
BU
09/01MAGELLAN HEALTH : Provides Free Consultation Services and Referrals to Local Community Res..
BU
08/30MAGELLAN HEALTH : Growth and Innovation Division at Magellan Health Announces New Appointm..
BU
More news
Analyst Recommendations on MAGELLAN HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 4 808 M - -
Net income 2021 35,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 76,8x
Yield 2021 -
Capitalization 2 490 M 2 490 M -
Capi. / Sales 2021 0,52x
Capi. / Sales 2022 0,48x
Nbr of Employees 9 000
Free-Float 46,2%
Chart MAGELLAN HEALTH, INC.
Duration : Period :
Magellan Health, Inc. Technical Analysis Chart | MGLN | US5590792074 | MarketScreener
Technical analysis trends MAGELLAN HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 94,79 $
Average target price 95,00 $
Spread / Average Target 0,22%
EPS Revisions
Managers and Directors
Kenneth J. Fasola Chief Executive Officer & Director
James E. Murray President & Chief Operating Officer
David Patrick Bourdon Chief Financial Officer
Steven J. Shulman Chairman
Caroline Carney Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
MAGELLAN HEALTH, INC.14.43%2 490
UNITEDHEALTH GROUP26.12%423 521
ANTHEM, INC.34.05%105 178
CIGNA CORPORATION3.87%73 599
HUMANA INC.12.32%59 350
CENTENE CORPORATION15.34%40 370